Psychological effects of chronic childhood diseases In common with children who have other chronic diseases, those with leukaemia experience a great many restrictions and disadvantages; school life is inevitably interrupted, and many children miss several months schooling immediately after diagnosis.' 2 All children are regularly absent during the course of their treatment either for routine hospital appointments, because of minor infections, or because of outbreaks of contagious diseases-such as measles or chickenpox-among the other children.
Such interruptions can have adverse consequences both for their academic achievements and for social relationships. Continued Given these restrictions and disadvantages, it should not be surprising that children with chronic diseases commonly show deficits in intellectual achievements,8 9 10 and in behavioural and social functioning. 1 " Certain 'risk' factors-especially social disadvantage or the occurrence of other medical complications, as well as the characteristics of the disease itself (such as the extent to which it is associated with visible deficits or reduces the child's mobility)-seem to aggravate the possibility of adverse psychological repercussions.'2 13 For those with leukaemia there is the additional 'risk factor' of their treatment regimens. Both radiotherapy and chemotherapy have been implicated as potential sources of damage to the developing central nervous system. Sometime after the introduction of this treatment protocol parents began to report difficulties for their children at school.'4 Typically, poor performance was noted especially in mathematics, problem solving, attention, and concentration skills.
Moss and Nannis argued that central nervous system prophylaxis may be particularly damaging for young children, as compensatory mechanisms are less likely to operate when radiation treatment includes the whole brain. 5 They hypothesised that greater intellectual impairment would also occur in younger children who received radiation treatment before the brain was fully developed (below 5 years). Deficits could be expected to become more noticeable with time. This hypothesis is based on the assumption that new learning is more affected than previously acquired skills, and that generalised damage early in life has a profound effect on the individual child.
Given parental reports of underachievement, and the possibility of radiation induced damage to the central nervous system, a considerable amount of research has been generated concerned with the short term and long term effects of treatment for leukaemia on the intelligence quotients (IQ) and academic achievements of children with the disease.
I will now consider how adequately this research has been designed and carried out, what conclusions can be drawn, and what implications may be drawn for the education of these children.
Problems in study design
To put the research findings into perspective, I
will first consider the problems in study design that are encountered in work of this kind.
First of all, it is impossible to show conclusively that any deficits in intelligence or behaviour that are observed are directly attributable to radiotherapy, chemotherapy, or any other disadvantages of the disease experienced by the child and family. For The number of children taking part was small, however, and there was a five year difference in the mean age of those with leukaemia treated by irradiation of the central nervous system and the control group with solid tumours. These findings were replicated in other studies. 7 20 A substantial number of reports, however, did suggest that children treated by irradiation of the central nervous system, or methotrexate, or both, did show IQ deficits compared with both healthy controls and with children with other cancers who were not treated in this way. The question became therefore not whether irradiation of the central nervous system was associated with deficits at all, but rather which children or skills were most vulnerable. Of these 30 studies, 17 were included in the meta-analysis, as only these fulfilled the criteria of having patients with acute lymphatic leukaemia who were treated with cranial irradiation as subjects and a control group in which irradiation was not used, and of providing enough statistical information for a full scale 'IQ effect size' to be calculated. The effect size was calculated from the difference between the mean scores of the control and treatment groups divided by the standard deviation of the control group scores. In addition, 10 variables were coded wherever possible, including the number of patients and controls, mean age at testing for patients and controls, age at diagnosis or irradiation for patients, number of units of radiation given, duration of treatment, time since treatment, type of control group, and IQ measuring instrument used.
The mean overall effect size was -0172, equivalent to an IQ deficit of about 11 points. Three variables correlated significantly with the effect size (p<005): (i) the age of the patients at the time of diagnosis (showing greater decrements the younger the patients were diagnosed); (ii) the age at testing of the controls (again showing greater decrements the younger they were at the time of testing); and (iii) the control group (greater decrements being found when healthy controls were compared with control groups who had other types of cancer).
The association between effect size and length of time since end Although the meta-analysis was excellent in the way in which it drew together much of the published work and indicated the mean decrement in IQ, it is an inappropriate technique for studying other issues. For example, it is still not clear whether patients have a generalised deficit in IQ, or whether specific skills are affected, nor is it clear whether IQ decrements are continuous and progressive, nor if there is a point at which scores stabilise, and even some recovery occurs. We know relatively little about the effects of irradiation as a function of gender, or social class, yet both these may be critical mediators of decrements.
Long term survivors Most of the work reviewed so far has been based on patients who were treated for leukaemia and survived without recurrence over relatively short periods of time (up to five years). As the numbers of patients who survive even longer has increased, interest has slowly shifted towards the consequences for those patients. Research concerned with long term survivors is of interest for two reasons. Firstly, it is necessary to establish whether children who are well, and have completed treatment, show the same kind of deficits as those who are in shorter term remission. This is relevant to the practical question of whether these children continue to need remedial help at a time when they are considered to be medically 'cured'. Secondly, the study of long term survivors is relevant to the issue of how irradiation of the central nervous system affects development; the issue is whether children's abilities are permanently blunted, or if and when intellectual recovery occurs.
Malpas suggested that achievements at school leaving age (in terms of examination passes) compared favourably with those of the rest of the population.36 Subtle deficits in long term survivors have, however, been identified by Mulhern were obtained in both reading and mathematics after consideration of scores before treatment and currently. Difficulties were noted particularly in attention and concentration, memory, sequencing, and comprehension. They argued that long term survivors showed specific deficits rather than generalised retardation. Despite this some children seemed to achieve appreciably more than expected, presumably reflecting the fact that individual or remedial help and parental support could do much to alleviate the potential damage of treatment of the leukaemia.
In a comparable study, Mulhern et al studied 183 children all of whom had been treated for cancer at least five years earlier and were currently free of disease.32 Problems with both academic work and adjustment were found among children who were older on beginning treatment, who had been treated by irradiation of the central nervous system, and who lived in one parent families. Both these studies pointed to the continuing need to support and offer remedial help to long term survivors. For children themselves interventions may need to foster intrapersonal and interpersonal skills in addition to focusing on academic abilities. Children with leukaemia may need to explain their disease, its treatment, and implications to others, and can experience considerable unease in doing so. These difficulties are of course shared by children with other chronic diseases. For example, those with diabetes may need to explain why they need injections, or why they may need to eat before physical activities. There is evidence that children with diabetes42' and asthma45 can benefit from training in 'social skills', which may help them resolve and deal with difficult social encounters. It may well be that these approaches need to be integrated with more straightforward educational interventions if we are really going to help children with leukaemia to be thoroughly integrated and competitive with their peers. 
